MARK LEACH: Open Payments
NPI 1699720763 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 103 payments from 10 companies in 2025. Trend: 2023 $2,237 · 2024 $3,180 · 2025 $3,301
Food & beverage: $2,946Education: $355
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 24 | $825 |
| UCB, Inc. | 21 | $752 |
| Janssen Biotech, Inc. | 14 | $487 |
| Galderma Laboratories, L.P. | 7 | $407 |
| ABBVIE INC. | 25 | $277 |
| PFIZER INC. | 7 | $232 |
| Novartis Pharmaceuticals Corporation | 2 | $165 |
| Journey Medical Corporation | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
Products named: DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, SKYRIZI, LITFULO, CIBINQO, RINVOQ.
Industry payments across FL — which companies pay providers there.
